Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Medical Food (Enterade) for the Reduction of Bowel Movement Frequency in Patients with Neuroendocrine Tumor

Neuroendocrine

This phase II trial studies how well a medical food called enterade works in reducing bowel movement frequency in patients with neuroendocrine tumor. is a commercially available amino acid-based medical food being developed to manage diarrhea due to neuroendocrine tumors either directly (carcinoid syndrome) or indirectly (non-carcinoid syndrome). It may also alleviate abdominal pain or discomfort, bloating, cramping and gas secondary to the disease. Enterade may alleviate neuroendocrine tumor associated diarrhea, provide control of bowel-related symptoms, and improve quality of life in neuroendocrine tumor patients with diarrhea.
Neuroendocrine
II
Das, Satya
NCT04073017
VICCGI1943

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: